Search Results

A novel α Globin Gene Cluster Duplication, αααα380 Heterozygous β0-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype

• Authors : Ju Long; Feifei Gong; Lei Sun

Subjects: Male; 03 medical and health sciences; 0302 clinical medicine

• Source: Hemoglobin. 47:25-30

Record details

The Effect of Blood Transfusion on Growth of Patients with Hb E/β-Thalassemia

• Authors : Ampaiwan Chuansumrit; Nongnuch Sirachainan; Pimpun Kitpoka

Subjects: Male; Adolescent; Hemoglobin E

• Source: Hemoglobin. 43:264-272

Record details

Blood Transfusion from a Hb E Trait Donor Can Affect β-Thalassemia Diagnosis.

• Authors : Pornprasert, Sakorn¹ (AUTHOR) ; Jaiping, Kanokwan² (AUTHOR)

• Source: Hemoglobin. 2014, Vol. 38 Issue 4, p295-298. 4p.

Record details

Blood Transfusion: Quality and Safety Issues in Thalassemia, Basic Requirements and New Trends.

• Authors : Porter, John¹ (AUTHOR)

• Source: Hemoglobin. Feb2009 Supplement 1, Vol. 33, pS28-S36. 9p.

Record details

Blood Transfusion in Sickle Cell Disease.

• Authors : Marouf, Rajaa¹ (AUTHOR)

• Source: Hemoglobin. Oct2011, Vol. 35 Issue 5/6, p495-502. 8p.

Record details

Low Dose Hydroxyurea is Effective in Reducing the Incidence of Painful Crisis and Frequency of Blood Transfusion in Sickle Cell Anemia Patients from Eastern India

• Authors : Ranjeet S. Mashon; Prasanta Purohit; B. S. Das

Subjects: Adult; Male; Adolescent

• Source: Hemoglobin. 36:409-420

Record details

Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.

• Authors : Bhattacharjee S; Institute of Haematology and Transfusion Medicine, Medical College and Hospital, Kolkata, India.; Ghosh S

Subjects: Quality of Life* ; Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/therapeutic use ; Hydroxyurea*/Hydroxyurea*/Hydroxyurea*/administration & dosage

• Source: Hemoglobin [Hemoglobin] 2024 May; Vol. 48 (3), pp. 161-168. Date of Electronic Publication: 2024 Aug 02.Publisher: Informa Healthcare Country of Publication: England NLM ID: 7705865 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

β-Thalassemia in Iran: Things Everyone Needs to Know About This Disease.

• Authors : Hadipour Dehshal, Mahmoud^1,2 (AUTHOR) ; Tabrizi Namini, Mehdi¹ (AUTHOR); Hantoushzadeh, Razieh³ (AUTHOR)

• Source: Hemoglobin. May2019, Vol. 43 Issue 3, p166-173. 8p.

Record details

Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.

• Authors : Manganas, Konstantinos¹ (AUTHOR); Delicou, Sophia¹ (AUTHOR); Xydaki, Aikaterini¹ (AUTHOR)

• Source: Hemoglobin. Mar2022, Vol. 46 Issue 2, p114-117. 4p.

Record details

Severe α-Thalassemia Due to Compound Heterozygosity for Hb Adana (α59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.

• Authors : Azimi, Azam¹ (AUTHOR); Tahmasebi, Susan¹ (AUTHOR); Moradi, Keivan² (AUTHOR)

• Source: Hemoglobin. Mar2020, Vol. 44 Issue 2, p139-142. 4p.

Record details